Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAib Group Regulatory News (AIBG)

Share Price Information for Aib Group (AIBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 421.50
Bid: 421.50
Ask: 423.50
Change: -4.00 (-0.94%)
Spread: 2.00 (0.474%)
Open: 426.50
High: 431.00
Low: 421.50
Prev. Close: 425.50
AIBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIB Group - Sale of non-performing loan portfolio

21 Jun 2022 07:00

RNS Number : 5577P
AIB Group PLC
21 June 2022
 

 

21 June 2022

 

AIB Group plc - SALE oF NON-PERFORMING LOAN PORTFOLIO; NPE RATIO BELOW 5%

 

AIB Group plc ("AIB") has agreed to sell a non-performing loan portfolio in long-term default to Everyday Finance DAC ("Everyday"), as part of a consortium that includes Everyday, affiliates of Cerberus Capital Management and LCM Partners Limited. This is another important step in reducing our non-performing exposures (NPE), resulting in a proforma NPE ratio of c. 4.4%* at March 2022 and ensuring we remain firmly on track to reach our c. 3% target by end 2023.

 

The sale of this portfolio, which includes multiple asset classes with an average time in default of c. 9 years, substantially resolves our legacy, long-term default NPEs. Normalising NPEs remains a priority delivering balance sheet resilience with improved risk profile, lower calendar provisioning and facilitates normalisation of our workout unit.

 

As at December 2021, the loan portfolio had a gross NPE value of c. €0.4 billion and a fully loaded risk-weighted assets (RWA) position of c. €0.3 billion. In the year ended 31 December 2021, the loan portfolio incurred a loss before tax and post-provisions of c. €46 million. 

 

At completion, AIB will receive cash consideration of approximately €0.4 billion. The proceeds will be used for general corporate purposes, including the continuation of support for customer restructuring. Overall the sale is expected to have a positive c. 40bps impact on CET1 covering P&L, calendar provisioning and RWA reduction.

 

Following the sale, all customers in the loan portfolio will continue to have the same regulatory protections, including protections under the Consumer Protection Code (CPC) and the Code of Conduct on Mortgage Arrears (CCMA). The loans will be sold with the benefit of existing protections under the customers' loan contracts.

 

Colin Hunt, AIB Chief Executive Officer said "Agreement of this transaction is an important milestone for AIB as it reduces the NPE ratio to well below 5%, resulting in a proforma NPE ratio of c. 4.4%* at Q1 2022. It demonstrates further progress as we move towards closing out legacy items this year while maintaining momentum in the delivery of our strategy."

 

Further information:

· The buyer, Everyday Finance DAC, is a regulated entity and will be responsible for all regulated activities in relation to the portfolio.

· Customers do not need to take any action following this announcement and AIB will now contact impacted customers to inform them that their loans are being transferred.

· AIB has reduced NPEs from c. €31 billion in 2013 to proforma c. €2.6 billion at end March 2022 following this transaction. This has primarily been achieved through customer engagement and case by case restructuring. AIB's strong preference is to work with customers to implement sustainable solutions and AIB continues to dedicate a considerable number of staff across the country to support customers who are in financial difficulty.

 

* Q1 2022 NPE ratio was 5.1%, the Q1 proforma NPE ratio of c. 4.4% takes into account this portfolio sale. It does not include the acquisitions of Ulster Bank's corporate and commercial loans nor its performing tracker mortgage portfolio.

 

-ENDS-

Contact details:

Niamh Hore / Siobhain Walsh

Paddy McDonnell / Graham Union

Investor Relations

Media Relations

AIB Group

AIB Group

Dublin

Dublin

Tel: +353-86-3135647 / +353-87-3956864

Tel: +353-87-7390743 / +353-85-2088343

email: niamh.a.hore@aib.ie

siobhain.m.walsh@aib.ie

 

 

email: paddy.x.mcdonnell@aib.ie

graham.x.union@aib.ie

 

Forward Looking Statements 

 

This document contains certain forward looking statements with respect to the financial condition, results of operations and business of AIB Group and certain of the plans and objectives of the Group. These forward looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward looking statements sometimes use words such as 'aim', 'anticipate', 'target', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'may', 'could', 'will', 'seek', 'continue', 'should', 'assume', or other words of similar meaning. Examples of forward looking statements include, among others, statements regarding the Group's future financial position, capital structure, Government shareholding in the Group, income growth, loan losses, business strategy, projected costs, capital ratios, estimates of capital expenditures, and plans and objectives for future operations. Because such statements are inherently subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward looking information. By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward looking statements. These are set out in the Principal risks on pages 28 to 30 in the 2021 Annual Financial Report. In addition to matters relating to the Group's business, future performance will be impacted by direct and indirect impacts of the COVID-19 pandemic and by Irish, UK and wider European and global economic and financial market considerations. Any forward looking statements made by or on behalf of the Group speak only as of the date they are made. The Group cautions that the list of important factors on pages 28 to 30 of the 2021 Annual Financial Report is not exhaustive. Investors and others should carefully consider the foregoing factors and other uncertainties and events when making an investment decision based on any forward looking statement.

Figures presented may be subject to rounding.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKKBNBBKBBAB
Date   Source Headline
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20246:01 pmRNSResult of Meeting
2nd May 20246:00 pmRNSResult of AGM
2nd May 20247:00 amRNSQ1 2024 Trading Statement
26th Apr 202410:13 amRNSRE EGM: Final Price in respect of Buyback Contract
24th Apr 20249:32 amRNSStabilisation Notice
23rd Apr 20245:16 pmRNSHolding(s) in Company
23rd Apr 20249:23 amRNSStabilisation Notice
3rd Apr 20243:00 pmRNSNotice of GM
3rd Apr 20243:00 pmRNSNotice of AGM
25th Mar 20248:34 amRNSHolding(s) in Company
11th Mar 20249:51 amRNSDirector/PDMR Shareholding
6th Mar 20247:15 amRNSDividend Declaration
6th Mar 20247:00 amRNS2023 Annual Financial Results Announcement
4th Mar 20244:25 pmRNSHolding(s) in Company
27th Feb 20242:23 pmRNSHolding(s) in Company
16th Feb 20243:35 pmRNSHolding(s) in Company
30th Jan 202412:36 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSFurther Renewal of the AIB share trading plan
14th Dec 20233:37 pmRNSHolding(s) in Company
11th Dec 20233:40 pmRNSHolding(s) in Company
24th Nov 20235:31 pmRNSHolding(s) in Company
8th Nov 20235:17 pmRNSHolding(s) in Company
8th Nov 202311:43 amRNSHolding(s) in Company
7th Nov 20235:35 pmRNSHolding(s) in Company
7th Nov 20237:08 amRNSAIB Group plc - Statement on State Divestment
7th Nov 20237:00 amRNSDisposal of approximately 5% of AIB Group plc
6th Nov 202311:34 amRNSHolding(s) in Company
1st Nov 20237:00 amRNSQ3 2023 Trading Statement
18th Oct 20239:58 amRNSStabilisation Notice
18th Oct 20239:00 amRNSHolding(s) in Company
16th Oct 20239:32 amRNSStabilisation Notice
11th Oct 20234:19 pmRNSHolding(s) in Company
21st Sep 20234:29 pmRNSHolding(s) in Company
1st Sep 20231:31 pmRNSHolding(s) in Company
21st Aug 20234:07 pmRNSHolding(s) in Company
28th Jul 20235:51 pmRNSEBA European-wide stress test 2023
28th Jul 20237:00 amRNSHalf-year Report 2023
13th Jul 20235:53 pmRNSHolding(s) in Company
11th Jul 202312:45 pmRNSHolding(s) in Company
30th Jun 20235:59 pmRNSHolding(s) in Company
30th Jun 20237:00 amRNSHolding(s) in Company
30th Jun 20237:00 amRNSHolding(s) in Company
28th Jun 20237:05 amRNSAIB Group plc - Statement on State Divestment
28th Jun 20237:00 amRNSResults of Secondary Placing in AIB Group plc
27th Jun 20235:09 pmRNSProposed Secondary Placing of Ordinary shares
23rd Jun 20233:27 pmRNSHolding(s) in Company
9th Jun 20233:56 pmRNSHolding(s) in Company
9th Jun 20237:00 amRNSHolding(s) in Company
1st Jun 20232:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.